Login to Your Account

Other News To Note

Friday, November 11, 2011
• Cytos Biotechnology Ltd., of Zurich, Switzerland, convened a bondholders' meeting on Nov. 10 to approve a proposed restructuring of outstanding convertible bonds, but failed to get sufficient votes to pass the proposal. Cytos said it will try to obtain further votes from bondholders who did not cast their votes.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription